EDX Medical Group Plc (AIM:EDX)

Market Cap	46.30M +10.6%
Revenue	n/a
Net Income	n/a
EPS	n/a
Shares Out	411.59M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	7,387
Open	11.08
Previous Close	11.25
Day's Range	10.50 - 12.00
52-Week Range	7.50 - 13.25
Beta	1.29
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About EDX Medical Group

EDX Medical Group Plc engages in developing a range of diagnostics testing solutions in the United Kingdom. It engages in the development of tests for diabetes, obesity, inflammatory disorders, and kidney and liver disorders. The company was formerly known as TECC Capital PLC and changed its name to EDX Medical Group Plc in November 2022. EDX Medical Group Plc was incorporated in 2021 and is based in Cambridge, the United Kingdom.

• Industry: Medical Laboratories
• Founded: 2021
• Country: United Kingdom
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: EDX

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Jul 27, 2026

Data Sources Report a data error